<DOC>
	<DOCNO>NCT02104154</DOCNO>
	<brief_summary>To establish performance characteristic Samsung LABGEO PT10 compare test result PT10 Hepatic assay result obtain FDA-cleared chemistry analyzer .</brief_summary>
	<brief_title>Evaluation Samsung LABGEO PT10 Hepatic Panel Point-of-Care Setting</brief_title>
	<detailed_description>To establish correlation measurand value obtain Samsung LABGEO PT10 Hepatic Panel point care , correspond measurand value obtain commercial clinical chemistry analyzer , respect prospectively collect human serum specimen .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<criteria>Male female subject history elevate liver enzymes symptoms suggestive elevate liver enzymes Presenting site require test level liver enzymes part routine care site Subjects able willing provide write informed consent Subjects unable unwilling provide write informed consent Subjects lifethreatening disease serious , potentially lifethreatening medical illness may compromise patient safety study conduct</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>